Dr. Weeks’ Comment: It is common practice for Big Pharma to offer “first authorship” as an incentive to doctors who will then prescribe a lot of their drug or who sit on advisory panels and are in a position to create “Pharma favorable” policies. Here is the first blow back on that insidious temptation.
“It’s a prostitution of their academic standing. And it undermines the integrity of the entire academic publication system.”
`
`
Academics ‘Guest Authoring’ Ghostwritten Medical Journal Articles Should Be Charged With Fraud, Legal Experts Argue
ScienceDaily (Aug. 2, 2011) ”” Two University of Toronto Faculty of Law professors argue that academics who ‘lend’ their names, and receive substantial credit, as guest authors of medical and scientific articles ghostwritten by industry writers, should be charged with professional and academic misconduct and fraud, even if they contain factually correct information.
In an article published in PLoS Medicine, Professors Simon Stern and Trudo Lemmens argue “Guest authorship is a disturbing violation of academic integrity standards, which form the basis of scientific reliability.” In addition, “The false respectability afforded to claims of safety and effectiveness through the use of academic investigators risks undermining the integrity of biomedical research and patient care.”
In “Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles,” Stern and Lemmens argue that since medical journals, academic institutions, and professional disciplinary bodies have not succeeded in enforcing effective sanctions, a more successful deterrence would be through the imposition of legal liability on the guest authors, “and may give rise to claims that could be pursued in a class action based on the Racketeer Influenced and Corrupt Organizations Act (RICO).”
The authors continue: “The same fraud could support claims of ‘fraud on the court’ against a pharmaceutical company that has used ghostwritten articles in litigation.” Such a claim could prevent the pharmaceutical sponsor of the articles from presenting them as evidence in court, and could also lead to sanctions against the lawyers who sought to treat the articles as legally valid evidence.
Concerns about ghostwriting have troubled the medical profession and editors of medical journals for years. Industry-sponsored articles, with only minor contributions from academic “guest authors,” have been published in leading medical journals, including articles on Hormone Replacement Therapies, Vioxx, Neurontin, Fen-Phen, and various anti-depressants. These articles are often cited by the pharmaceutical sponsors to promote off-label use of their products.
Lemmens, who is also cross-appointed to the Faculty of Medicine, has tough words for academics who participate in this guest authorship-ghostwriting dance. “It’s a prostitution of their academic standing. And it undermines the integrity of the entire academic publication system.”
The research is supported by a grant from the Social Sciences and Humanities Research Council on The Promotion of Integrity in Biomedical Research.
Journal Reference:
- Simon Stern, Trudo Lemmens. Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles. PLoS Medicine, 2011; 8 (8): e1001070 DOI: 10.1371/journal.pmed.1001070